Transcranial laser therapy alters amyloid precursor protein processing and improves mitochondrial function in a mouse model of Alzheimer's Disease

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 7887, Issue , 2011, Pages

  McCarthy, Thomas ^a   Yu, Jin ^b   El Amouri, Salim ^b,f   Gattoni Celli, Sebastiano ^b,c   Richieri, Steve ^a   De Taboada, Luis ^a   Streeter, Jackson ^d   Kindy, Mark S ^b,e  

^a PhotoThera Inc   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^d BANYAN BIOMARKERS INC   (United States)

^e Neurological Testing Service Inc   (United States)

^f CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER'S DISEASE; AMYLOID PLAQUES; AMYLOID PRECURSOR PROTEINS; ATP LEVEL; CLEAVAGE PRODUCTS; CONTROL GROUPS; DOSE-DEPENDENT; LASER SYSTEMS; LASER THERAPY; LASER TREATMENT; MITOCHONDRIAL ACTIVITY; MITOCHONDRIAL FUNCTION; MOUSE MODELS; NEAR INFRARED; OXYGEN UTILIZATION; SECRETASES; TRANSCRANIAL;

ANIMALS; BRAIN; DISEASE CONTROL; GLYCOPROTEINS; LASER TISSUE INTERACTION; MITOCHONDRIA; NEURODEGENERATIVE DISEASES; OXYGEN; PROTEINS;

INFRARED LASERS;

EID: 79955503980     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.877028     Document Type: Conference Paper

References (55)

1. Karu T (1996) Mechanisms of interaction of monochromatic visible light with cells. Proc Soc Photogr Instrum Eng 2630, 2-9.
2. Karu T (2000) Mechanisms of low power laser light action on cellular level. Proc Soc Photogr Instrum Eng 4159, 1-17.
3. Streeter J, De Taboada L, Oron U (2004) Mechanisms of action of light therapy for stroke and acute myocardial infarction. Mitochondrion 4, 569-576. (Pubitemid 39646807)
4. Zivin JA, Albers GW, Bornstein N, Chippendale T, Dahlof B, Devlin T, Fisher M, Hacke W, Holt W, Ilic S, Kasner S, Lew R, Nash M, Perez J, Rymer M, Schellinger P, Schneider D, Schwab S, Veltkamp R, Walker M, Streeter J; NeuroThera Effectiveness and Safety Trial-2 Investigators (2009) Effectiveness and safety of transcranial laser therapy for acute ischemic stroke. Stroke 40, 1359-1364.
5. Lapchak PA, Han MK, Salgado KF, Streeter J, Zivin JA (2008) Safety profile of transcranial near-infrared laser therapy administered in combination with thrombolytic therapy to embolized rabbits. Stroke 39, 3073-3078.
6. Oron A, Oron U, Chen J, Eilam A, Zhang C, Sadeh M, Lampl Y, Streeter J, DeTaboada L, Chopp M (2006) Low-level laser therapy applied transcranially to rats after induction of stroke significantly reduces long-term neurological deficits. Stroke 37, 2620-2624. (Pubitemid 44454688)
7. De Taboada L, Ilic S, Leichliter-Martha S, Oron U, Oron A, Streeter J (2006) Transcranial application of lowenergy laser irradiation improves neurological deficits in rats following acute stroke. Lasers in Surgery and Medicine 38, 70-73. (Pubitemid 43238086)
8. Lapchak PA, Wei J, Zivin JA (2004) Transcranial infrared laser therapy improves clinical rating scores after embolic strokes in rabbits. Stroke 35, 1985-1988. (Pubitemid 38971888)
9. Lampl Y, Zivin JA, Fisher M, Lew R, Welin L, Dahlof B, Borenstein P, Andersson B, Perez J, Caparo C, Ilic S, Oron U (2007) Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1). Stroke 38, 1843-1849. (Pubitemid 46847257)
10. Oron A, Oron U, Streeter J, de Taboada L, Alexandrovich A, Trembovler A, Shohami E (2007) Low-level laser therapy applied transcranially to mice following traumatic brain injury significantly reduces long-term neurological deficits. Journal of Neurotrauma 24, 651-656. (Pubitemid 46996025)
11. Eells JT, Henry MM, Summerfelt P, Wong-Riley MT, Buchmann EV, Kane M, Whelan NT, Whelan HT (2003) Therapeutic photobiomodulation for methanol-induced retinal toxicity. Proceedings of the National Academy of Science 100, 3439-3444. (Pubitemid 36356602)
12. Wong-Riley MT, Bai X, Buchmann E, Whelan HT (2001) Light-emitting diode treatment reverses the effect of TTX on cytochrome oxidase in neurons. NeuroReport 12, 3033-3037. (Pubitemid 32907000)
13. Tuner J, Hode L (2002) Laser Therapy - Clinical Practice and Scientific Background, Prima Books, Grängesberg, Sweden.
14. Lapchak, P.A., De Taboada, L (2010) Transcranial near infrared laser treatment (NILT) increases cortical adenosine-5'-triphosphate (ATP) content following embolic stroke in rabbits. Brain Res 1306, 100-105.
15. Lynn BC, Wang J, Markesbery WR, Lovell MA (2010) Quantitative Changes in the Mitochondrial Proteome from Subjects with Mild Cognitive Impairment, Early Stage, and Late Stage Alzheimer's Disease. Journal of Alzheimer's Disease 19, 325-339.
16. Moreira PI, Carvalho C, Zhu X, Smith MA, Perry G (2009) Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology. Biochimica Biophysica Acta 1802, 2-10.
17. Selkoe DJ (1991) The molecular pathology of Alzheimer's disease. Neuron 6, 487-498.
18. Selkoe DJ (1994) Normal and abnormal biology of the beta-amyloid precursor protein. Ann Rev Neurosci 17, 489- 517. (Pubitemid 24117040)
19. Selkoe DJ (1999) Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399, Suppl, A23-31.
20. Selkoe DJ (2001) Presenilin, Notch, and the genesis and treatment of Alzheimer's disease. Proc Nat Acad Sci U S A 98, 11039-11041. (Pubitemid 32928679)
21. J Buxbaum JD, Liu KN, Luo Y, Slack JL, Stocking KL, Peschon JJ, Johnson RS, Castner BJ, Cerretti DP, Black RA (1998) Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J Biol Chem 273, 27765-27767. (Pubitemid 28496060)
22. Cai H, Wang Y, McCarthy D, Wen H, Corchelt DR, Price DL, Wong PC (2001) BACE 1 is the major β-secretase for generation of Aβ by neurons. Nat Neurosci 4, 233-234. (Pubitemid 32194867)
23. Checler F (1995) Processing of the beta-amyloid precursor protein and its regulation in Alzheimer's disease. J Neurochem 65, 1431-1444.
24. De Strooper B, Annaert W (2000) Proteolytic processing and cell biological functions of the amyloid precursor protein. J Cell Sci 113, 1857-1870. (Pubitemid 30386490)
25. Galasko D, Hansen LA, Katzman R, Wiederholt W, Masliah E, Terry R, Hill LR, Lessin P, Thal LJ (1994) Clinical-neuropathological correlations in Alzheimer's disease and related dementias. Arch Neurol 51, 888-895. (Pubitemid 24286043)
26. Haass C, Selkoe D (1993) Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta peptide. Cell 75, 1039-1042.
27. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, Yu C, Jondro PD, Schmidt SD, Wang K, Crowley AC, Fu Y-H, Guenette SY, Galas D, Nemens E, Wijsman EM, Bird TD, Schellenberg GD, Tanzi RE (1995) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269, 973-977.
28. Lin X, Koelsch G, Wu S, Downs D, Dashti A, Tang J (2000) Human aspartic protease memapsin 2 cleaves the β- secretase site of β-amyloid precursor protein. Proc Nat Acad Sci USA 97, 1456-1460. (Pubitemid 30118462)
29. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Nat Acad Sci USA 90, 1977-1981. (Pubitemid 23069980)
30. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gathier S (1993) Apolipoprotein E polymorphism and Alzheizer 's disease. Lancet 342, 697-699.
31. Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, Chi H, Lin C, Holman K, Tsuda T, Mar L, Sorbi S, Nacmias B, Piacentini S, Amaducci L, Chumakov I, Cohen D, Lannfelt L, Fraser PE, Rommens JM, St George-Hyslop PH (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376, 775-778.
32. Roberds SL, Anderson J, Basi G, Bienkowski MJ, Branstetter DG, Chen KS, Freedman SB, Frigon NL, Games D, Hu K, Johnson-Wood K, Kappenman KE, Kawabe TT, Kola I, Kuehn R, Lee M, Liu W, Motter R, Nichols NF, Power M, Robertson DW, Schenk D, Schoor M, Shopp GM, Shuck ME, Sinha S, Svensson KA, Tatsuno G, Tintrup H, Wijsman J, Wright S, McConlogue L (2001) BACE knockout mice are healthy despite lacking the primary β-secretase activity in the brain: implications for Alzheimer's disease therapeutics. Hum Mol Gen 10, 1317-1324. (Pubitemid 32600485)
33. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin J-F, Bruni AC, Montesi MP, Sorbi S, Rainero I, Pinessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinsky RJ, Wasco W, Da Silva HAR, Haines JL, Pericak-Vance MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM, St George-Hyslop PH (1995) Cloning of a gene bearing missense mutations in earlyonset familial Alzheimer's disease. Nature 375, 754-760.
34. Sinha S, Anderson JP, Barbour R, Basi GS, Caccavello R, Davis D, Doan M, Dovey HF, Frigon N, Hong J, Jacobson-Croak K, Jewett N, Keim P, Knops J, Lieberburg I, Power M, Tan H, Tatsuno G, Tung J, Schenk D, Seubert P, Suomensaari SM, Wang S, Walker D, Zhao J, McConlogue L, John V (1999) "Purification and cloning of amyloid precursor protein β-secretase from human brain. Nature 402, 537-540.
35. St. George-Hyslop PH (1993) The molecular genetics of Alzheimer's disease. Raven Press, New York, NY.
36. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller J, Edenson S, Lile J, Jarosinski MA, Biere AL, Curran E, Burgess T, Louis JC, Collins F, Treanor J, Rogers G, Citron M (1999) β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735-741.
37. Weihofen A, Binns K, Lemberg MK, Ashman K, Martoglio B (2002) Identification of signal peptide peptidase, a presenilin-type aspartic protease. Science 296, 2215-2218. (Pubitemid 34680305)
38. Hook VY, Kindy M, Reinheckel T, Peters C, Hook G (2009) Genetic cathepsin B deficiency reduces betaamyloid in transgenic mice expressing human wild-type amyloid precursor protein. Biochem Biophys Res Commun 386, 284-288.
39. Guo JT, Yu J, Grass D, de Beer FC, Kindy MS (2002) Inflammation-dependent cerebral deposition of serum amyloid a protein in a mouse model of amyloidosis. J Neurosci 15, 5900-5909. (Pubitemid 35387634)
40. Fisher RL, Gandolfi AJ, Brendel K (2001) Human liver quality is a dominant factor in the outcome of in vitro studies. Cell Biol Toxicol 17, 179-189. (Pubitemid 32971560)
41. Yu J, Novgorodov SA, Chudakova D, Zhu H, Bielawska A, Bielawski J, Obeid LM, Kindy MS, Gudz TI. (2007) JNK3 signaling pathway activates ceramide synthase leading to mitochondrial dysfunction. J Biol Chem 282, 25940-25949. (Pubitemid 47372813)
42. Wu X, Dmitriev AE, Cardoso MJ, Viers-Costello AG, Borke RC, Streeter J, Anders JJ (2009) 810 nm Wavelength light: an effective therapy for transected or contused rat spinal cord. Lasers Surg Med 41, 36-41.
43. Byrnes KR, Waynant RW, Ilev IK, Wu X, Barna L, Smith K, Heckert R, Gerst H, Anders JJ (2005) Light promotes regeneration and functional recovery and alters the immune response after spinal cord injury. Lasers Surg Med 36, 171-85.
44. Rochkind S, Shahar A, Amon M, Nevo Z (2002) Transplantation of embryonal spinal cord nerve cells cultured on biodegradable microcarriers followed by low power laser irradiation for the treatment of traumatic paraplegia in rats. Neurological Res 24, 355-60. (Pubitemid 34627758)
45. El-Amouri SS, Zhu H, Yu J, Marr R, Verma IM, Kindy MS (2008) Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease. Amer J Pathol 172, 1342-1354. (Pubitemid 351671547)
46. Rocchi A, Orsucci D, Tognoni G, Ceravolo R, Siciliano G (2009) The role of vascular factors in late-onset sporadic Alzheimer's disease. Genetic and molecular aspects. Curr Alz Res 6, 224-237.
47. Arancio O, Zhang HP, Chen X, Lin C, Trinchese F, Puzzo D, Liu S, Hegde A, Yan SF, Stern A, Luddy JS, Lue LF, Walker DG, Roher A, Buttini M, Mucke L, Li W, Schmidt AM, Kindy M, Hyslop PA, Stern DM, Du Yan SS (2004) RAGE potentiates Abeta-induced perturbation of neuronal function in transgenic mice. Euro Mole Biol Org J 23, 4096-4105. (Pubitemid 39472430)
48. Hickman SE, Allison EK, El Khoury J (2008) Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J Neurosci 28, 8354-8360.
49. Oron U, Yaakobi T, Oron A, Mordechovitz D, Shofti R, Hayam G, Dror U, Gepstein L, Wolf T, Haudenschild C, Haim SB (2001) Low-energy laser irradiation reduces formation of scar tissue after myocardial infarction in rats and dogs. Circulation 103, 296-301. (Pubitemid 32095418)
50. Oron U, Yaakobi T, Oron A, Hayam G, Gepstein L, Rubin O, Wolf T, Ben Haim S (2001) Attenuation of the formation of scar tissue in rats and dogs post myocardial infarction by low energy laser irradiation. Lasers Surg Med 28, 204-211. (Pubitemid 32275286)
51. Yaakobi T, Shoshany Y, Levkovitz S, Rubin O, Ben Haim SA, Oron U (2001) Long-term effect of low laser irradiation on infarction and reperfusion injury in the rat heart. J Applied Phys 90, 2411-2419. (Pubitemid 32467437)
52. Sheffer G, Patridge TA, Heslop L, Gross JG, Oron U, Halvey O (2002). Low-energy laser irradiation promotes the survival and cell cycle of skeletal muscle satellite cells. J Cell Sci 115, 1-9.
53. Avni, D., Levkovitz, S., Maltz, L., and Oron, U. (2005). Protection of skeletal muscle from ischemia/reperfusion injury by low energy laser irradiation. Photomed. Laser Surg. 23, 273-277.
54. Donmez G, Wang D, Cohen DE, Guarente L. (2010). SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10. Cell.142(2), 320-32.
55. van Tetering, G., van Diest, P., Verlaan, I., van der Wall, E., Kopan, R., and Vooijs, M. (2009). The metalloprotease ADAM10 is required for Notch1 S2 cleavage. J. Biol. Chem. 284, 31018-31027.